- MD Anderson appoints inaugural chief nurse executive
- Children’s Mercy plans $1B+ patient care tower
- AI detects pancreatic cancer 3 years before diagnosis: Mayo Clinic
- Hospital finance leaders zero in on capacity optimization + workforce effectiveness as margins remain thin
- Jefferson Health lands $1.7M grant for hypertension care
- CMS may have improperly paid $2.26M for virtual services: Audit
- GLP-1 semaglutide tied to vision risk: Study
- NYC Health + Hospitals launches avian flu preparedness program
- How the Nicklaus Children’s-Broward Health pediatric ecosystem is faring 60 days in
- 22 behavioral health executive moves to know
- MemorialCare CEO takes on new role; successor named
- The ‘significant opportunity’ Talkspace will bring to UHS
- Physician lawsuit rates hit historic lows, but malpractice premiums are soaring: AMA
- Showing the work: How hospitals can build a credible 340B narrative
- The potential ‘litigation wave’ headed for GI
- ASCs’ multi-billion dollar savings potential
- Dental’s new cash-pay anesthesia opportunity
- The new cash-pay anesthesia opportunity
- UHS-owned behavioral health facility to lay off 648 employees
- PeaceHealth physician group switch-up heads to court
- Why ophthalmology ASCs have a built-in advantage
- Georgia Southern University to begin construction of new dental school
- Oregon institute receives $3M cardiovascular gift
- 2 GI centers adopt AI liver diagnostics platform
- Ohio hospital launches outpatient neurology clinic
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- Tennessee dental school to open clinic in Kentucky
- Federal autism committee outlines policy, care gaps in HHS letter
- Tennessee provider expands virtual behavioral health urgent care
- Chicago invests $16.2M in mental health, street psychiatry program
- US suicide rate declines 2%: 5 things to know
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- AstraZeneca CEO's conservative MFN model excludes reference markets from forecast
- With Austedo at helm, Teva's impressive innovative drug sales signal company's successful metamorphosis
- Universal Health Services' Q1 2026 earnings growth dampened by volume hits
- AbbVie outlines Skyrizi defense against new J&J plaque psoriasis rival Icotyde
- Regeneron's quarterly sales of Eylea drop below $1B for the first time in 8 years
- Only 1 in 4 employers able to ‘absorb’ increasing health benefit costs without impacting business
- Dementia Screening Safe For Families, Trial Finds
- Online Program Soothes Post-Trauma Stress In Injured Children
- Mental Defeat Can Worsen Chronic Pain, Researchers Say
- Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds
- New GSK CEO’s first quarter boosted by Shingrix surge as Exdensur stumbles in switch trial
- AstraZeneca restarts £300M investment in UK, but Merck not budging
- Chiesi lays out $1.9B to bolster rare disease offerings with KalVista buyout
- Trump’s Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Saving Lives by Changing Lives: The Next Frontier in Suicide Prevention
- Pfizer looks to jump start Elrexfio with topline win in second-line myeloma
- The push to expand access to emergency contraception
- Humana pulls back the curtain on planning for 2027 MA bids
- Lawmakers introduce bill to expand mental health clinics
- What 5 dentists would do differently in their careers
- Psychedelics show promise but are ‘not a solution’ to mental healthcare gap, MGB leader says
- Beyond the note: How ambient AI solves behavioral health’s unique challenges
- CareQuest, NxtCare partner to integrate oral health with home-based care
- Heartland Dental adds Texas practice
- 6 dental deals totaling $148M
- Viewpoint: Dentistry needs to ‘outsmart’ the insurance industry
- 16 DSOs expanding on the East Coast
- Dental AI software secures FDA clearance
- On Capitol Hill, health system CEOs agree to 'rational reworking' of site-neutral payments
- Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies
- Secret to Surviving 'Perfect Mom' Posts on Social Media Revealed
- Pfizer’s victory in delaying Vyndamax generics is mixed bag for BridgeBio: analysts
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Getting All Your Ducks in a Row to IPO: Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Remarks to the Small Business Capital Formation Advisory Committee
- FDA flags concerns for AstraZeneca's camizestrant, Truqap ahead of advisory committee meeting
- CDC Warns of Antibiotic-Resistant Salmonella in Backyard Flocks
- Listen to the Latest ‘KFF Health News Minute’
- AI-driven coding platform Arintra rolls out new documentation improvement capabilities
- Florida Delays Children's Health Insurance Expansion as Uninsured Rate Rises
- Interoperability was Never the Finish Line in Healthcare
- Interoperability was Never the Finish Line in Healthcare
- IKS Health to acquire TruBridge in $557M deal
- FDA turns up heat on Amgen, proposing to rescind approval of Tavneos
- Rocket sells priority review voucher for $180M after Kresladi gene therapy approval
- Big companies position themselves for payday from $50B federal rural health fund
- AZ's Breztri nabs FDA asthma nod, adding fuel to blockbuster launch
- Haleon scores branding goal with star-studded soccer offensive
- Daylight Saving Time Fails to Boost Daily Steps, Study Finds
- Metabolic Syndrome Tied To Cancer Risk
- Mail-In Colon Cancer Test Kits Offer Affordable Screening
- U.S. Dentists Still Overprescribing Opioids Compared To Other Nations, Puerto Rico
- Novartis stands by $5B Pluvicto goal despite European regulatory setback, bispecific competition
- An Urgent Care Treated Her Allergic Reaction. An ER Monitored Her — For $6,700.
- Big Companies Position Themselves for Payday From $50B Federal Rural Health Fund
- Centene swings to $1.5B profit as Medicaid business improves even as ACA membership falls by 2 million
- CCS deploys enterprise-wide agentic AI across chronic care operations
- Utah Medical Licensing Board urges state to shut down Doctronic AI prescribing pilot
- Estrogen Patch Shortages Likely Driven By Empowered Women Seeking Relief, Expert Says
- GSK's Tesaro unit dealt pre-trial blow in Jemperli feud with AnaptysBio
- Medical professional liability premiums rise for 7th straight year
- UChicago Medicine, Artisight partner on system-wide rollout of smart hospital platform
- Solace Health expands care navigation services to commercially insured patients
- First Gene Therapy for Genetic Hearing Loss, Otarmeni, Gains FDA Approval
- Mundipharma, CorMedix eye antifungal expansion after Rezzayo trial win
- CMS Extends Medicare's Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
- Humana's CenterWell, Mark Cuban Cost Plus Drugs partner to tackle employers' drug costs
- Pfizer settles with 2 generic Vyndamax makers in latest twist to ATTR market: analysts
- Haleon nabs Google exec Richard Manso as US chief marketing officer
- Astellas counts on new medicines to offset projected Xtandi decline in fiscal 2026
- Sun Pharma strikes biopharma's largest deal of '26 with $11.75B buyout of Organon
- AMA urges lawmakers to implement stronger safeguards for AI chatbots in mental health
- Blood Glucose Monitors Improve Control Among Type 2 Diabetes Patients
- Regaining Weight After Quitting Your GLP-1 Drug? A Simple Procedure Might Help, Study Says
- Late-Night Noshing Could Contribute To Stress-Related Bathroom Problems
- Ligand snaps up fellow biotech royalty aggregator Xoma for $739M
- New Treatment Targets Unaddressed Major Symptom Of Depression Through Joy, Pleasure and Purpose
- Florida Delays Children’s Health Insurance Expansion as Uninsured Rate Rises
- The Help That Many Older Americans Need Most
- UnityAI builds out agentic AI for staffing operations to match outpatient clinicians with patient demand
- Why Pricier Olive Oil May Be Better For Your Brain
- Your Internal Signal to Stop Eating is More Complex Than Previously Thought
- Gounder Culls the News, From Ticks and AI to Who Might Lead CDC
- FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
- In Connecticut, Doctors and Dentists Are More Likely Than Hospitals To Sue Patients
- Green Lighting Capital Formation: Remarks at the SEC International Institute on Capital Formation
- Lawmakers introduce bipartisan legislation to improve access, quality of care in Medicare Advantage plans
- HCA Healthcare executives shrug off Q1 volumes disruptions, reaffirm FY2026 guidance
- With ‘lessons learned,’ Kite prepares to hit the ground running as next-gen CAR-T decision looms
- Former Tobacco Executive Takes CDC Role
- New Plan Could Speed Medicare Coverage for Innovative Devices
- ‘What the Health?’ Podcast: RFK Jr. vs. Congress
- Heated Socks Sold at Costco Recalled After Burn Reports
- First Measles Case of the Year Reported in New Jersey
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- Health Tech Weekly Rundown: Google invests in AI training for rural health workers; State of genAI adoption in healthcare
- UnitedHealthcare, Aetna, Cigna tout progress to standardize prior authorization as part of industry-wide commitment
- Does Motherhood Shield You From Stroke?
- These Fun Pursuits Help Middle-Aged Folks Protect Brain Health, Study Finds
- New Guidelines Highlight Behavioral Therapy For Insomnia
- Playing Pretend Provides Unexpected Benefits For Growing Kids
- New Survey Estimates 8 Million Americans Used Psilocybin in 2024
- Eye Photos Might Offer Early Warning Of Chronic Health Problems, AI Study Finds
- A look at payers' attitudes toward specialty drug management
- 988 Hotline Leads to Fewer Suicides Among Young People, Study Finds
- Drop in NIH Funding Delays Thousands of Studies
- U.K. Plans To Ban Cigarette Sales for Future Generations
- Website Helps Dementia Patients And Caregivers Bond, Reminisce
- Gene Cure For Inherited Deafness Effective, Long Lasting, Clinical Trial Finds
- New Treatment, Dato-DXd, Improves Survival for Aggressive Breast Cancer
- ER Study Finds Major Gaps in Measles Immunity
- Opening Remarks at the 32nd Annual International Institute for Securities Market Growth and Development
- Keynote Remarks at The Economic Club of Washington
- Rethinking Prior Authorization for Better Outcomes
- Statement on the Amendments to Form PF
- Update on the SEC’s Work Toward Treasury Clearing Implementation
- A look at the National Academy of Medicine’s Change Maker Accelerators Program
Robert F. Kennedy, Jr. was excoriated by Democratic Senators during nomination hearings before the Senate Finance & the Health, Education, Labor and Pensions Committees. Curiously, RFK, Jr. happens to still be a Democrat. One possible reason for his abuse at the hand of his fellow Democrats would be the Democratic Senators consider him an apostate for participating in President Trump's campaign and victory. The other possibility is the Democratic Senators are owned body and soul by Big Pharma and other anti MAHA (Make America Healthy Again) interests.
The Democratic propagandists in the main stream media are not covering this story because Champagne Socialist Bernie Sanders and Heap Big Faker Elizabeth "Pocahontas" Warren seem to be the most thoroughly compromised, but the story is getting some traction in alternative media:
RFK Jr. Exposes Big Pharma-Backed Senators During His Confirmation Hearing
By RVM News Staff - January 31, 2025Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services (HHS) sparked contentious debate in the Senate this week, bringing renewed attention to the influence of pharmaceutical and health industry donations on lawmakers.
During a Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on Thursday, Kennedy defended his record against critics while senators questioning him found their own financial ties to the healthcare industry under scrutiny.
Senate HELP Committee Chair Bill Cassidy (R-LA) questioned Kennedy’s past statements on vaccines, including those related to measles and Hepatitis B.
While expressing concerns over Kennedy’s views, Cassidy acknowledged the nominee’s broad popular support.
“My responsibility is to learn, to try to understand if you can be trusted to support the best public health,” Cassidy said.
“A worthy movement called MAHA [Make America Healthy Again] to improve the health of Americans, or to undermine it, always asking for more evidence and never accepting the evidence that is there. That’s my dilemma, man. So you may be hearing from me over the weekend.”
Meanwhile, Kennedy and his supporters have pointed to the role of pharmaceutical industry donations in the confirmation process.
“Our kids are getting sicker and sicker. All of the people here who are defending this current system, and defending these pharmaceutical profits, are taking huge amounts of money from the pharmaceutical industry,” Kennedy said.
“This is not making our country healthier. It’s making our country sicker. We need to get rid of these conflicts.”
The role of industry donations in the confirmation process has drawn heightened attention, particularly regarding members of the Senate Finance Committee and the HELP Committee.
The watchdog group OpenSecrets has tracked contributions from pharmaceutical companies, health professionals, and related industries to committee members over the past five years.
Senate Finance Committee Ranking Member Ron Wyden (D-OR) has received significant contributions from the health sector between 2019 and 2024, including $749,316 from health professionals, $652,004 from insurers, $539,242 from health services and HMOs, and $502,063 from the pharmaceutical industry.
His top donors include Blue Cross/Blue Shield and Centene Corporation.
Cassidy, who expressed uncertainty over Kennedy’s confirmation, received $1,623,298 from health professionals and $996,737 from the pharmaceutical industry from 2019 to 2025, with Ochsner Health System as one of his top donors.
Even senators known for their criticism of the pharmaceutical industry have come under scrutiny.
Sen. Elizabeth Warren (D-MA) raised concerns that Kennedy’s lawsuits against pharmaceutical companies could financially damage vaccine manufacturers.
However, Warren has received $498,074 from health professionals, $126,056 from the pharmaceutical industry, and $109,065 from hospitals and nursing homes over the same period.
Sen. Bernie Sanders (I-VT), a longtime critic of corporate influence, has received $115,690 from the pharmaceutical industry and $159,233 from the food and beverage industry.
Sen. Bernie Sanders speaks at Erie High School in support of the Harris/Walz presidential campaign in Erie on Oct. 26, 2024.
During Kennedy’s testimony, Sanders was challenged on the $1,417,633 in contributions from pharmaceutical industry employees during his 2020 presidential campaign.“The problem of corruption is not just in the federal agencies. It’s in the Congress too,” Kennedy said.
“Almost all the members of this panel, including yourself, are accepting millions of dollars from the pharmaceutical industry and protecting their interests.”
Sanders defended his contributions, stating, “I ran for president like you. I got millions and millions of contributions. They did not come from the executives, not one nickel of PAC money from the pharmaceutical industry. They came from workers.”
Beyond campaign contributions, several senators overseeing Kennedy’s confirmation hold personal financial interests in industries that could be affected by his policies.
Wyden’s spouse owns stock valued between $50,000 and $100,000 in Restaurant Brands International Inc., which owns Burger King, Popeyes, and Firehouse Subs, as well as an investment worth between $1,001 and $15,000 in Pfizer.
Sen. Susan Collins (R-ME), a member of the HELP Committee, has financial ties to multiple industries regulated by HHS.
Her spouse owns stocks valued between $15,000 and $50,000 in companies such as EcoLab Inc., The Hershey Company, Johnson & Johnson, Merck & Co., and Thermo Fisher Scientific Inc.
Sen. Mark Warner (D-VA) has between $1 million and $5 million invested in Health Velocity Capital I, LP, a hedge fund focusing on healthcare technology, along with between $250,000 and $500,000 in Health Velocity II, LP, a venture capital fund.
While many senators on both sides of the aisle remain skeptical of Kennedy’s nomination, some have voiced strong support.
Sen. Marsha Blackburn (R-TN), one of the top recipients of pharmaceutical industry contributions in 2023-2024, has endorsed Kennedy’s nomination.
“It’s time to confirm RFK Jr. as HHS Secretary. He is ready to MAHA,” Blackburn said during the Senate Finance Committee hearing.
Kennedy’s confirmation remains uncertain as senators weigh his nomination against their own industry ties, with both his critics and supporters facing public scrutiny over their financial relationships with the healthcare sector.
In the 2019-20 Congressional funding cycle, Sanders received more money from people employed in the field classified by Open Secrets as "pharmaceuticals/health products" ($1.4 million) than any other member of Congress. He also received roughly $400,000 from people employed in "pharmaceutical manufacturing."
Elizabeth Warren raked in roughly $5 million from the health industry during her presidential bid in 2020.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.













